0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug Repositioning Service Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-33Y5606
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Drug Repositioning Service Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Drug Repositioning Service Market Research Report 2025

Code: QYRE-Auto-33Y5606
Report
July 2025
Pages:68
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Drug Repositioning Service Market Size

The global market for Drug Repositioning Service was valued at US$ 28860 million in the year 2024 and is projected to reach a revised size of US$ 39630 million by 2031, growing at a CAGR of 4.7% during the forecast period.

Drug Repositioning Service Market

Drug Repositioning Service Market

Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Repositioning Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Repositioning Service.
The Drug Repositioning Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Repositioning Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Repositioning Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Drug Repositioning Service Market Report

Report Metric Details
Report Name Drug Repositioning Service Market
Accounted market size in year US$ 28860 million
Forecasted market size in 2031 US$ 39630 million
CAGR 4.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Cardiovascular Diseases
  • Mental Illness
  • Cancer
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Biovista, Anaxomics Biotech, Segue Therapeutics, GVK Biosciences, LTT Bio-Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Drug Repositioning Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Drug Repositioning Service Market growing?

Ans: The Drug Repositioning Service Market witnessing a CAGR of 4.7% during the forecast period 2025-2031.

What is the Drug Repositioning Service Market size in 2031?

Ans: The Drug Repositioning Service Market size in 2031 will be US$ 39630 million.

Who are the main players in the Drug Repositioning Service Market report?

Ans: The main players in the Drug Repositioning Service Market are Biovista, Anaxomics Biotech, Segue Therapeutics, GVK Biosciences, LTT Bio-Pharma

What are the Application segmentation covered in the Drug Repositioning Service Market report?

Ans: The Applications covered in the Drug Repositioning Service Market report are Cardiovascular Diseases, Mental Illness, Cancer, Other

What are the Type segmentation covered in the Drug Repositioning Service Market report?

Ans: The Types covered in the Drug Repositioning Service Market report are Generic Drugs, Clinical Trial Failed Drugs

Recommended Reports

Pharmaceutical Services

Drug Testing & Storage

Drug Discovery & Development

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Repositioning Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Generic Drugs
1.2.3 Clinical Trial Failed Drugs
1.3 Market by Application
1.3.1 Global Drug Repositioning Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cardiovascular Diseases
1.3.3 Mental Illness
1.3.4 Cancer
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Repositioning Service Market Perspective (2020-2031)
2.2 Global Drug Repositioning Service Growth Trends by Region
2.2.1 Global Drug Repositioning Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drug Repositioning Service Historic Market Size by Region (2020-2025)
2.2.3 Drug Repositioning Service Forecasted Market Size by Region (2026-2031)
2.3 Drug Repositioning Service Market Dynamics
2.3.1 Drug Repositioning Service Industry Trends
2.3.2 Drug Repositioning Service Market Drivers
2.3.3 Drug Repositioning Service Market Challenges
2.3.4 Drug Repositioning Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Repositioning Service Players by Revenue
3.1.1 Global Top Drug Repositioning Service Players by Revenue (2020-2025)
3.1.2 Global Drug Repositioning Service Revenue Market Share by Players (2020-2025)
3.2 Global Drug Repositioning Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug Repositioning Service Revenue
3.4 Global Drug Repositioning Service Market Concentration Ratio
3.4.1 Global Drug Repositioning Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Repositioning Service Revenue in 2024
3.5 Global Key Players of Drug Repositioning Service Head office and Area Served
3.6 Global Key Players of Drug Repositioning Service, Product and Application
3.7 Global Key Players of Drug Repositioning Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Repositioning Service Breakdown Data by Type
4.1 Global Drug Repositioning Service Historic Market Size by Type (2020-2025)
4.2 Global Drug Repositioning Service Forecasted Market Size by Type (2026-2031)
5 Drug Repositioning Service Breakdown Data by Application
5.1 Global Drug Repositioning Service Historic Market Size by Application (2020-2025)
5.2 Global Drug Repositioning Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drug Repositioning Service Market Size (2020-2031)
6.2 North America Drug Repositioning Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drug Repositioning Service Market Size by Country (2020-2025)
6.4 North America Drug Repositioning Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Repositioning Service Market Size (2020-2031)
7.2 Europe Drug Repositioning Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drug Repositioning Service Market Size by Country (2020-2025)
7.4 Europe Drug Repositioning Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Repositioning Service Market Size (2020-2031)
8.2 Asia-Pacific Drug Repositioning Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drug Repositioning Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Drug Repositioning Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Repositioning Service Market Size (2020-2031)
9.2 Latin America Drug Repositioning Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drug Repositioning Service Market Size by Country (2020-2025)
9.4 Latin America Drug Repositioning Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Repositioning Service Market Size (2020-2031)
10.2 Middle East & Africa Drug Repositioning Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drug Repositioning Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Drug Repositioning Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biovista
11.1.1 Biovista Company Details
11.1.2 Biovista Business Overview
11.1.3 Biovista Drug Repositioning Service Introduction
11.1.4 Biovista Revenue in Drug Repositioning Service Business (2020-2025)
11.1.5 Biovista Recent Development
11.2 Anaxomics Biotech
11.2.1 Anaxomics Biotech Company Details
11.2.2 Anaxomics Biotech Business Overview
11.2.3 Anaxomics Biotech Drug Repositioning Service Introduction
11.2.4 Anaxomics Biotech Revenue in Drug Repositioning Service Business (2020-2025)
11.2.5 Anaxomics Biotech Recent Development
11.3 Segue Therapeutics
11.3.1 Segue Therapeutics Company Details
11.3.2 Segue Therapeutics Business Overview
11.3.3 Segue Therapeutics Drug Repositioning Service Introduction
11.3.4 Segue Therapeutics Revenue in Drug Repositioning Service Business (2020-2025)
11.3.5 Segue Therapeutics Recent Development
11.4 GVK Biosciences
11.4.1 GVK Biosciences Company Details
11.4.2 GVK Biosciences Business Overview
11.4.3 GVK Biosciences Drug Repositioning Service Introduction
11.4.4 GVK Biosciences Revenue in Drug Repositioning Service Business (2020-2025)
11.4.5 GVK Biosciences Recent Development
11.5 LTT Bio-Pharma
11.5.1 LTT Bio-Pharma Company Details
11.5.2 LTT Bio-Pharma Business Overview
11.5.3 LTT Bio-Pharma Drug Repositioning Service Introduction
11.5.4 LTT Bio-Pharma Revenue in Drug Repositioning Service Business (2020-2025)
11.5.5 LTT Bio-Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Drug Repositioning Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Generic Drugs
 Table 3. Key Players of Clinical Trial Failed Drugs
 Table 4. Global Drug Repositioning Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Drug Repositioning Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Drug Repositioning Service Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Drug Repositioning Service Market Share by Region (2020-2025)
 Table 8. Global Drug Repositioning Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Drug Repositioning Service Market Share by Region (2026-2031)
 Table 10. Drug Repositioning Service Market Trends
 Table 11. Drug Repositioning Service Market Drivers
 Table 12. Drug Repositioning Service Market Challenges
 Table 13. Drug Repositioning Service Market Restraints
 Table 14. Global Drug Repositioning Service Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Drug Repositioning Service Market Share by Players (2020-2025)
 Table 16. Global Top Drug Repositioning Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repositioning Service as of 2024)
 Table 17. Ranking of Global Top Drug Repositioning Service Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Drug Repositioning Service Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Drug Repositioning Service, Headquarters and Area Served
 Table 20. Global Key Players of Drug Repositioning Service, Product and Application
 Table 21. Global Key Players of Drug Repositioning Service, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Drug Repositioning Service Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Drug Repositioning Service Revenue Market Share by Type (2020-2025)
 Table 25. Global Drug Repositioning Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Drug Repositioning Service Revenue Market Share by Type (2026-2031)
 Table 27. Global Drug Repositioning Service Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Drug Repositioning Service Revenue Market Share by Application (2020-2025)
 Table 29. Global Drug Repositioning Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Drug Repositioning Service Revenue Market Share by Application (2026-2031)
 Table 31. North America Drug Repositioning Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Drug Repositioning Service Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Drug Repositioning Service Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Drug Repositioning Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Drug Repositioning Service Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Drug Repositioning Service Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Drug Repositioning Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Drug Repositioning Service Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Drug Repositioning Service Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Drug Repositioning Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Drug Repositioning Service Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Drug Repositioning Service Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Drug Repositioning Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Drug Repositioning Service Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Drug Repositioning Service Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Biovista Company Details
 Table 47. Biovista Business Overview
 Table 48. Biovista Drug Repositioning Service Product
 Table 49. Biovista Revenue in Drug Repositioning Service Business (2020-2025) & (US$ Million)
 Table 50. Biovista Recent Development
 Table 51. Anaxomics Biotech Company Details
 Table 52. Anaxomics Biotech Business Overview
 Table 53. Anaxomics Biotech Drug Repositioning Service Product
 Table 54. Anaxomics Biotech Revenue in Drug Repositioning Service Business (2020-2025) & (US$ Million)
 Table 55. Anaxomics Biotech Recent Development
 Table 56. Segue Therapeutics Company Details
 Table 57. Segue Therapeutics Business Overview
 Table 58. Segue Therapeutics Drug Repositioning Service Product
 Table 59. Segue Therapeutics Revenue in Drug Repositioning Service Business (2020-2025) & (US$ Million)
 Table 60. Segue Therapeutics Recent Development
 Table 61. GVK Biosciences Company Details
 Table 62. GVK Biosciences Business Overview
 Table 63. GVK Biosciences Drug Repositioning Service Product
 Table 64. GVK Biosciences Revenue in Drug Repositioning Service Business (2020-2025) & (US$ Million)
 Table 65. GVK Biosciences Recent Development
 Table 66. LTT Bio-Pharma Company Details
 Table 67. LTT Bio-Pharma Business Overview
 Table 68. LTT Bio-Pharma Drug Repositioning Service Product
 Table 69. LTT Bio-Pharma Revenue in Drug Repositioning Service Business (2020-2025) & (US$ Million)
 Table 70. LTT Bio-Pharma Recent Development
 Table 71. Research Programs/Design for This Report
 Table 72. Key Data Information from Secondary Sources
 Table 73. Key Data Information from Primary Sources
 Table 74. Authors List of This Report


List of Figures
 Figure 1. Drug Repositioning Service Picture
 Figure 2. Global Drug Repositioning Service Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Drug Repositioning Service Market Share by Type: 2024 VS 2031
 Figure 4. Generic Drugs Features
 Figure 5. Clinical Trial Failed Drugs Features
 Figure 6. Global Drug Repositioning Service Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Drug Repositioning Service Market Share by Application: 2024 VS 2031
 Figure 8. Cardiovascular Diseases Case Studies
 Figure 9. Mental Illness Case Studies
 Figure 10. Cancer Case Studies
 Figure 11. Other Case Studies
 Figure 12. Drug Repositioning Service Report Years Considered
 Figure 13. Global Drug Repositioning Service Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Drug Repositioning Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Drug Repositioning Service Market Share by Region: 2024 VS 2031
 Figure 16. Global Drug Repositioning Service Market Share by Players in 2024
 Figure 17. Global Top Drug Repositioning Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repositioning Service as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Drug Repositioning Service Revenue in 2024
 Figure 19. North America Drug Repositioning Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Drug Repositioning Service Market Share by Country (2020-2031)
 Figure 21. United States Drug Repositioning Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Drug Repositioning Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Drug Repositioning Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Drug Repositioning Service Market Share by Country (2020-2031)
 Figure 25. Germany Drug Repositioning Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Drug Repositioning Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Drug Repositioning Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Drug Repositioning Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Drug Repositioning Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Drug Repositioning Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Drug Repositioning Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Drug Repositioning Service Market Share by Region (2020-2031)
 Figure 33. China Drug Repositioning Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Drug Repositioning Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Drug Repositioning Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Drug Repositioning Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Drug Repositioning Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Drug Repositioning Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Drug Repositioning Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Drug Repositioning Service Market Share by Country (2020-2031)
 Figure 41. Mexico Drug Repositioning Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Drug Repositioning Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Drug Repositioning Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Drug Repositioning Service Market Share by Country (2020-2031)
 Figure 45. Turkey Drug Repositioning Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Drug Repositioning Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Drug Repositioning Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Biovista Revenue Growth Rate in Drug Repositioning Service Business (2020-2025)
 Figure 49. Anaxomics Biotech Revenue Growth Rate in Drug Repositioning Service Business (2020-2025)
 Figure 50. Segue Therapeutics Revenue Growth Rate in Drug Repositioning Service Business (2020-2025)
 Figure 51. GVK Biosciences Revenue Growth Rate in Drug Repositioning Service Business (2020-2025)
 Figure 52. LTT Bio-Pharma Revenue Growth Rate in Drug Repositioning Service Business (2020-2025)
 Figure 53. Bottom-up and Top-down Approaches for This Report
 Figure 54. Data Triangulation
 Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS